Povoljni učinci primjene ekstrakta kore nara na antropometriju i tjelesni sastav kod gojaznih dijabetes melitus tip 2 pacijenata: Randomizovana, dvostruko slijepa, placebo kontrolisana studija
Scindeks Asistent Scindeks Asistent — sistem za ozbiljne časopise i one koji to žele da postanu

Sažetak

Background: Pomegranate is a rich source of a wide variety of polyphenol compounds with beneficial pharmacological activities for treating diabetes mellitus type 2 (DMT2). Most of DMT2 patients are overweight or obese and obesity by itself is linked to insulin resistance and abnormalities in insulin secretion. The aim of this study was to evaluate the effects of pomegranate peel extract (PoPEx) on anthropometry and body composition of overweight patients with DMT2.

Methods: Sixty patients with DMT2 on continuous metformin therapy were recruited in this double-blind, placebo-controlled, randomized clinical trial. The study group (n=30) received capsules containing PoPEx (250 mg) twice a day for 8 weeks’ period, and the placebo group (n=30) received placebo capsules for the same period. Anthropometric characteristics (weight, waist circumference, fat mass percentage, visceral fat level) were measured at baseline and at the end of the study.

Results: Eight weeks’ treatment with PoPEx resulted in significant changes in BMI (0.18 ± 0.30 kg/m2) and body mass (0.48 ± 0.93 kg). The intake of PoPEx produced a significant decrease in waist circumference z=-4.613, p<0.001 (r=0.60) indicating a large effect size using Cohen-d test, and a non-significant decrease in the level of visceral fat. The results showed a nonsignificant reduction in fat mass percentage in PoPEx group (-0.58 ± 2.21 %, p꓿0.159) compared with the placebo group (0.14 ± 1.24 %, p꓿0.546).

Conclusion: The eight-weeks supplementation with PoPEx had a beneficial effect on anthropometry and body composition of overweight diabetic patients.

Ključne reči

Array
DOI: 10.5937/scriptamed51-25763

Reference

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

Preuzimanja

Podaci o preuzimanju još nisu dostupni.